Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jan;93(1):188-94.
doi: 10.1172/JCI116944.

Platelet-activating factor causes ventilation-perfusion mismatch in humans

Affiliations

Platelet-activating factor causes ventilation-perfusion mismatch in humans

R Rodriguez-Roisin et al. J Clin Invest. 1994 Jan.

Abstract

We hypothesized that platelet-activating factor (PAF), a potent inflammatory mediator, could induce gas exchange abnormalities in normal humans. To this end, the effect of aerosolized PAF (2 mg/ml solution; 24 micrograms) on ventilation-perfusion (VA/Q) relationships, hemodynamics, and resistance of the respiratory system was studied in 14 healthy, nonatopic, and nonsmoking individuals (23 +/- 1 [SEM]yr) before and at 2, 4, 6, 8, 15, and 45 min after inhalation, and compared to that of inhaled lyso-PAF in 10 other healthy individuals (24 +/- 2 yr). PAF induced, compared to lyso-PAF, immediate leukopenia (P < 0.001) followed by a rebound leukocytosis (P < 0.002), increased minute ventilation (P < 0.05) and resistance of the respiratory system (P < 0.01), and decreased systemic arterial pressure (P < 0.05). Similarly, compared to lyso-PAF, PaO2 showed a trend to fall (by 12.2 +/- 4.3 mmHg, mean +/- SEM maximum change from baseline), and arterial-alveolar O2 gradient increased (by 16.7 +/- 4.3 mmHg) (P < 0.02) after PAF, because of VA/Q mismatch: the dispersion of pulmonary blood flow and that of ventilation increased by 0.45 +/- 0.1 (P < 0.01) and 0.29 +/- 0.1 (P < 0.04), respectively. We conclude that in normal subjects, inhaled PAF results in considerable immediate VA/Q inequality and gas exchange impairment. These results reinforce the notion that PAF may play a major role as a mediator of inflammation in the human lung.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am Rev Respir Dis. 1991 Jun;143(6):1345-9 - PubMed
    1. Am Rev Respir Dis. 1991 Jul;144(1):88-94 - PubMed
    1. Clin Sci (Lond). 1992 Aug;83(2):127-38 - PubMed
    1. Am Rev Respir Dis. 1992 Oct;146(4):1003-8 - PubMed
    1. J Appl Physiol Respir Environ Exerc Physiol. 1977 Jun;42(6):889-98 - PubMed

Publication types